AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 SEP 19 - (NewsRx.com & NewsRx.net) -- Antiabortion groups petitioned the U.S. Food and Drug Administration August 21, 2002, to halt sales of the abortion pill Mifeprex, saying the agency shouldn't have approved it almost 2 years ago.
The American Association of Pro-Life Obstetricians and Gynecologists, Christian Medical Association and Concerned Women for America argued that FDA bent its own rules in approving Mifeprex, including eliminating safeguards required during the pill's testing.
The groups called the drug dangerous for women, citing FDA's report last April of five Mifeprex users with health problems, including two who suffered ruptured ectopic pregnancies, one fatal.
Mifeprex does not abort an ectopic, or tubal, pregnancy, and is not supposed to be given to women with that life-threatening condition.
The other reports included two women with infections, one fatal, and one heart attack. The FDA hasn't determined that the drug played any role in the cases.
The FDA said it would review the petition, which puts in ...